Resectable hilar cholangiocarcinoma: surgical treatment and long-term outcome

Michael I D'Angelica; William R Jarnagin; Leslie H Blumgart

doi:10.1007/s00595-004-2832-3

Resectable hilar cholangiocarcinoma: surgical treatment and long-term outcome

Surg Today. 2004;34(11):885-90. doi: 10.1007/s00595-004-2832-3.

Authors

Michael I D'Angelica¹, William R Jarnagin, Leslie H Blumgart

Affiliation

¹ Department of Surgery, Hepatobiliary Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

PMID: 15526120
DOI: 10.1007/s00595-004-2832-3

Abstract

Unresected hilar cholangiocarcinoma has a dismal prognosis, but advances in staging and surgical techniques have given well-selected patients a chance of long-term survival if curative resection is possible. This review summarizes the state of the art in diagnosis, treatment, and outcome for patients with biliary obstruction at the hilus of the liver.

Publication types

Comparative Study
Review

MeSH terms

Bile Duct Neoplasms / mortality
Bile Duct Neoplasms / pathology*
Bile Duct Neoplasms / surgery*
Bile Ducts, Intrahepatic*
Cholangiocarcinoma / mortality
Cholangiocarcinoma / pathology*
Cholangiocarcinoma / surgery*
Female
Follow-Up Studies
Hepatectomy / methods*
Humans
Male
Preoperative Care / methods
Risk Assessment
Survival Analysis
Time Factors
Treatment Outcome